Springer Protocols: Abstract: Multiple Opioid Receptors in the Central Nervous System

Multiple Opioid Receptors in the Central Nervous System

By: Paul L. Wood¹

Abstract

Full Text

Download PDF (1952K)

The initial landmarks in opioid receptor research were the demonstration of stereospecificity (Becket and Casey, 1954) and the identification of receptor sites in central nervous system (CNS) membrane preparations (Pert and Snyder, 1973; Simon et al., 1973). Subsequent behavioral studies with a number of opiate agonists suggested that more than one opioid receptor population was present in the CNS (Martin et al., 1976; Gilbert and Martin, 1976). The concept of multiple opioid receptors has been extensively investigated, and present data indicate that three major opioid receptor populations are present in the brain (Iwamoto and Martin, 1981; Zukin and Zukin, 1981; Wood, 1982). These are the mu (μ), delta (δ), and kappa (κ) sites.

Affiliation(s): (1) Pharmaceuticals Diviszon, Neurosciences Research, CUBA-GEIGY Corporation, Summit, New Jersey, USA

Book Title: Receptor Binding

Series: Neuromethods | Volume: 4 | Pub. Date: Jun-20-1986 | Page Range: 329-363 | DOI: 10.1385/0-89603-078-4:329

Subject: Neuroscience

References

Download References

Ahtee L. and Kaariainen I (1973) The effect of narcotic analgesics on the homovanillic acid content of rat nucleus caudatus Eur. J. Pharmacol 22, 206–208.

Akil H., Hewlett W. A., Barchas J. D., and Li C. H. (1980) Binding of ³H-β-endorphm to rat brain membranes Characterization of opiate receptors and mteractron with ACTH. Eur J. Pharmacol 64, 1–8.

Algeri A., Brunello N., Calderini G., and Consolazione A (1978) Effect of enkephalins on catecholamine metabolism in rats CNS Adv Biochem Psychopharmacol 18, 199–209

Attali B., Gouardéres L., Mazarguil H., Audigier Y., and Cros J. (1982) Evidence for multiple “kappa” binding sites by use of opioid peptides in the guinea pig lumbosacral spinal cord Neuropeptides 3, 53–64

Atweh S F and Kuhar M. J (1977) Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla Brain Res 124, 53–67.

Audigier Y., Attali B, Mazarguil H, and Cros J (1982) Characterization of [³H]-etorphine binding in guinea pig striatum after blockade of mu and delta sites. Life Sci. 31, 1287–1290

Barnard E. A and Demoliou-Mason C. (1983) Molecular properties of opioid receptors Brit. Med. Bull. 39, 37–45.

Becket A H and Casey A F. (1954) Synthetic analgesics Stereo-chemical considerations. J. Pharm. Pharmacol 6, 986–1001

Bliss C I. and James A. T. (1966) Fitting the rectangular hyperbola. Biometrics 22, 573–602

Burgisser E. (1984) Radioligand-receptor binding studies. What’s wrong with the Scatachard analysis? Trends Pharmacol. Sci 5, 142–144

Chang K J. and Cuatrecasas P. (1979) Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity. J. Biol. Chem. 254, 2610–2618

Chang K. J,, Killian A., Hazum E., Cuatrecasas P., and Chang J. K. (1981a) Morphiceptin (NH₄-Tyr-Pro-Phe-Pro-CONH₂): A potent and specific agonist for morphine (p) receptors. Science 212, 75–77

Chavkin C., James I. F., and Goldstein A (1982) Dynorphin is a specific endogenous ligand of the κ opioid receptor Science 215, 413–415

Cheney D L, Trabucchi M., Racagni G, Wang C, and Costa E (1974) Effects of acute and chronic morphine on regional rat brain acetylcholine turnover rate. Life Sci. 15, 1977–1990.

Childers S.R., Creese I., Snowman A. M., and Snyder S H (1979) Opiate receptor binding affected differentially by opiates and opioid peptides. Eur. J. Pharmacol 55, 11–18.

Costa E., Cheney D L, Racagni G, and Zsilla G (1975) An analysis at the synaptic level of the morphine action in striatum and N. accumbens. Dopamme and acetylcholine mteractions Life Sci. 17, 1–8

Duka T., Wuster M., Schubert P., Stoiber R., and Herz A. (1981) Selective localization of different types of opiate receptors in hippocampus as revealed by in vitro autoradiography. Brain Res. 205, 181–186

Ferrara P and Li C. H. (1980) β-Endorphm Characteristics of binding sites in rabbit spinal cord. Proc Natl. Acad. Sci USA 77, 5746–5748.

Fields H. L., Emson P. C, Leigh B K., Gibert R F. T., and Iversen L. L. (1980) Multiple opiate receptor sites on primary afferent fibers. Nature (Lond.) 284, 351–353.

Finnerty E. P. and Chan S. H. H (1979) Morphine suppression of substantia nigra zona reticulata neurons in the rat. Implicated role for a novel striatomgral feedback mechanism Eur. J Pharmacol 59, 307–310

Foote R. W. and Maurer R. (1982) Autoradiographic localization of opiate κ-receptors in the guinea pig brain. Eur. J. Pharmacol 85, 99–103

Foote R. W. and Maurer R (1983) Kappa opiate binding sites in the substantia nigra and bulbus olfactorius of the guinea pig as shown by in vitro autoradiography Life Sci. 33, 243–246.

Gamse R., Holzer P, and Lembeck F. (1979) Indirect evidence for presynaptic location of opiate receptors on chemosensitive primary sensory neurons. Naunyn-Schmiedeberg’s Arch. Pharmacol 308, 281–285

Gardner E. L, Zukin R. S, and Makman M. H (1980) Modulation of opiate receptor binding in striatum and amygdala by selective mesencephalic lesions. Brain Res 194, 232–239

Garzon J., Sanchez-Blazquez P, Gerhart J., Loh H. H, and Lee N. M (1984) Dynorphin A. Inhibitory effect on other opiate ligand bindings in the mouse brain. Biochem. Pharmacol 33, 2609–2614.

Gauchy C., Agid Y., Glowinski J., and Cheramy A. (1973) Acute effects of morphine on dopamine synthesis and release and tyrosine metabolism in the rat striatum. Eur J Pharmacol 22, 311–319.

Gilbert P. E. and Martm W. R (1976) The effects of morphine-and nalorphine-like drugs in nondependent morphine-dependent and cyclazocine-dependent chronic spinal dog J Pharmacol Exp Ther. 198, 66–82.

Gillan M G C. and Kosterlitz H W (1982) Spectrum of the μ-, δ-, and κ-binding sites in homogenates of rat brain Brit. J. Pharmacol 77, 461–469.

Gommeren W. and Leysen J. E (1982) Binding characteristics of ³H-lofentanil at the opiate receptor. Arch Int Pharmacodyn. 258, 171–173

Goodman R R., Snyder S H., Kuhar M J, and Young W S. (1980) Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography Proc Natl. Acad Sci USA 77, 6239–6243.

Goodman R R. and Snyder S. H (1982) Kappa opiate receptors localized by autoradiography to deep layers of cerebral cortex. relation to sedative effects. Proc. Natl. Acad. Sci. USA 79, 5703–5707

Guidotti A, Moroni F, Gale K, and Kumakura K. (1978) Opiate Receptor Stimulation Blocks the Activation of Striatal Tyrosme Hydroxylase (TH) Induced by Haloperidol, in Catecholamines: Basic and Clinical Frontiers (Usdin E., Kopin I. J., and Barchas J., eds ) Pergamon Press, New York, pp. 1035–1037.

Hahn E. F., Carroll-Buatti M., and Pasternak G. W. (1982) Irreversible opiate agonists and antagonists: The 14-hydroxydihydromorphinone azines. J. Neuroscience 2, 572–576.

Harris D. W. and Sethy V. H. (1980) High affinity binding of [³H]-ethylketocyclazocine to rat brain homogenate Eur. J. Pharmacol. 66, 121–123.

Herling S. and Woods J. H. (1981) Discriminative stimulus effects of narcotics: Evidence for multiple receptor-mediated actions. Life Sci. 28, 1571–1584.

Hiller J. M., and Simon E J, (1980) Specific high affinity [³H]-ethylketocyclazocine binding in rat central nervous system. Lack of evidence for μ receptors J. Pharmacol Exp. Ther 214, 516–519

Hiller J. M. Angel L M., and Simon E. J. (1984) Characterization of the selective inhibition of the delta subclass of opioid binding sites by alcohols Mol. Pharmacol 25, 249–255.

Hughes J. (1975) Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine Brain Res 88, 295–308.

Itzhak Y., Hiller J M, and Simon E. J. (1984) Solubilization and characterization of μ-, δ-, and κ-Opioid binding sites from guinea pig brain: Physical separation of κ receptors. Proc. Natl Acad Sci USA 81, 4217–4221.

Iwamoto E T. and Martin W. R. (1981) Multiple opioid receptors Med. Res. Rev. 1, 411–440

Iwatsuba K and Clouet D. H (1977) Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons J. Pharmacol Exp Ther 202, 429–436.

James I. F., Chavkin C, and Goldstein A. (1982) Preparation of brain membranes containing a single type of oploid receptor highly selective for dynorphin Proc Natl. Acad Sci USA 79, 7570–7574

Kelly P. D, Rance M J., and Traynor J. R (1982) Properties of opiate binding in the rat spinal cord. Neuropeptides 2, 319–324

Klotz I. M. (1982) Numbers of receptor sites from Scatchard graphics Facts and fantasies. Science 217, 1247–1249.

Kosterlitz H. W. and Paterson S J. (1980) Characterization of opioid receptors in nervous tissue. Proc. Roy. Sot. Lond (B ) 210, 113–122.

Lamotte C., Pert C. B, and Snyder S, H. (1976) Opiate receptor binding in primate spinal cord: Distribution and changes after dorsal root section Brain Res. 112, 407–412.

Law P. Y, Loh H. H., and Li C H. (1979) Properties and localization of β-endorphin receptor in rat brain Proc Natl. Acad. Sci. USA 76, 5455–5459.

Lewis M. E., Young E. A., Houghten R. A., Akil H., and Watson S. J, (1984) Binding of [³H]-dynorphin to apparent κ opioid receptors in deep layers of guinea pig cerebral cortex. Eur. J. Pharmacol 98, 149–150

Ling G. S. F., Spiegel K, Nishimura S L., and Pasternak G. W. (1983) Dissociation of morphine’s analgesic and respiratory depressant actions. Eur J Pharmacol 86, 487–488.

Loew G. H., Toll L., and Keys C (1983) Computer-assisted analysis of receptor-binding studies of [³H]-naloxone and [³H]-DADLA reinterpretation of the Na⁺ effect. Life Sci. 33, 163–166.

Martin W. R., Eades C. G, Thompson J M., Huppler R E, and Gilbert P. E. (1976) The effects of morphine-and nalorphine-like drugs in the non-dependent chronic spinal dog J. Pharmacol. Exp Ther. 197, 517–532.

Maurer R. (1982) Multiplicity of opiate receptors in different species. Neurosc. Lett 30, 303–307

Meibach R. C. and Mayani S. (1980) Localization of naloxone-sensitive [³H]-dihydromorphine binding sites within the hippocampus of the rat. Eur J, Pharmacol. 68, 175–179.

Moleman P. and Bruinvels J. (1979) Effect of morphine on dopaminergic neurons in the rat basal forebrain and striatum. J Neural. Transm. 46, 225–237.

Moroni F., Cheney D. L., and Costa E. (1977) Inhibition of acetylcholine turnover in rat hippocampus by intraseptal injections of β-endorphin and morphine Naunyn-Schmiedeberg’s Arch. Pharmacol. 299, 149–153

Moroni F., Cheney D. L., and Costa E. (1978) The turnover rate of acetylcholine in brain nuclei of rats injected intraventricularly and intraseptally with alpha and beta-endorphin Neuropharmacology 17, 191–196.

Moroni F., Peralta E., Cheney D. L.,and Costa E. (1979) On the regulation of γ-aminobutyric acid neurons in caudatus, pallidus, and nigra: Effects of opioids and dopamine agonists J. Pharmacol. Exp Ther 208, 190–194.

Mosberg H. I., Hurst R., Hruby V. J., Gee K., Akiyama K., Yamamura M I., Galligan J. J., and Burks T. F. (1983) Cyclic pennicillamine containing enkephalin analogs displays profound delta receptor selectivities. Life Sci. 33, 447–450.

Murrin L. C, Coyle J. T., and Kuhar M. J. (1980) Striatal opiate receptors. Pre-and postsynaptic localization Life Sci 27, 1175–1183

Nowycky M. C., Walters J, R, and Roth R. H. (1978) Dopaminergic neurons: Effect of acute and chronic morphine administration on single cell activity and transmitter metabolism. J. Neural. Transm. 49, 99–116.

Pasternak G. W. and Snyder S. H. (1975a) Opiate receptor binding: Enzymatic treatments that discriminate between agonist and antagonist interactions. Mol. Pharmacol. 11, 478–484.

Pasternak G. W. and Snyder S. H. (1975b) Identification of novel high-affinity opiate receptor binding in rat brain. Nature (Lond.) 253, 563–565.

Pasternak G. W. (1980) Multiple opiate receptors. [³H]-Ethylketocyclazotine receptor binding and ketocyclazocine analgesia. Proc. Natl. Acad. Sci. USA 77, 3691–3694.

Pasternak G. W., Carroll-Buatti M., and Spiegel K. (1981) The binding and analgesic properties of a sigma opiate, SKF 10047 J. Pharmacol. Exp. Ther. 219, 192–198.

Pasternak G W. (1982) High and low affinity opioid binding sites Relationship to mu and delta sites. Life Sci. 31, 1303–1306.

Pert C.B and Snyder S H (1973) Properties of opiate-receptor binding in rat brain. Proc. Natl. Acad. Sci. USA 70, 2243–2247.

Pert C. B. and Snyder S. H. (1974) Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol. Pharmacol. 10, 868–879.

Pert C. B. and Taylor D (1979) Type 1 and Type 2 Opiate Receptors; A Subclassification Scheme Based upon GTP’s Differential Effects on Binding, in Endogenous and Exogenous Opiate Agonists and Antagonists (Way E. L., ed.) pp. 87–90, Pergamon, New York.

Pfeiffer A. and Herz A. (1981) Demonstration and distribution of an opiate binding site in rat brain with high affinity for ethylketocyclazotine and SKF 10047. Biochem. Biophys. Res. Commun. 101, 38–44

Pfeiffer A., Pasi A., Mehraein P, and Herz A. (1981) A subclassification of κ-sites in human brain by use of dynorphin 1–17 Neurupeptides 2, 89–97.

Pfeiffer A. and Herz A (1982) Discrimination of three opiate-receptor binding sites with the use of a computerized curve-fitting technique Mol. Pharmacol. 21, 266–671.

Pilapil C. and Wood P L. (1983) [³H]-SKE 10047 binding to rat brain membranes: Evidence for kappa rsoreceptors. Life Sci. 33, 263–265.

Pollard H., Llorens C., and Schwartz J. C. (1977) Enkephalin receptors on dopammergic neurons in rat striatum. Nature (Lond.) 268, 745–747.

Pollard H., Llorens C., Schwartz J. C, Gros C, and Dray F (1978) Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system. Lesion studies. Brain Res 151, 392–398.

Quirion R, Hammer R. P., Herkenham M., and Pert C B (1981) Phencyclidine (angel dust) σ “opiate” receptor. Visualization by trrtium-sensitive film. Proc. Natl Acad Sci. USA 78, 5881–5885

Quirion R., Bowen W.D., Herkenham M,and Pert C B. (1982) Visualization and solubilization of rat brain opiate receptors with a “κ” ligand selectivity pattern. Cell Mol Neurobiol. 2, 333–346.

Robson L E. and Kosterhtz H W (1979) Specific protection of the binding sites of D-Ala²-D-Leu enkephalin (δ-receptors) and drhydromorphine (μ-receptors). Proc Roy. Soc. Land. (B.) 205, 425–432

Robson L. E, Gillan M G C., McKnight A T, and Kosterlitz H. W (1983) [³H]-Dynorphin A(1–9). Binding characteristics and degradation profile in brain homogenates. Life Sci 33, 283–286.

Roemer D., Buscher H., Hill R. C, Maurer R., Petcher T. J, Welle H B. A, Bake1 H. C. E. K., and Akkerman A. M. (1980) Bramazocine. A potent long-acting opiate kappa-agonist. Life Sci. 27, 971–978.

Sadee W., Rosenbaum J. S, and Herz A. (1982) Buprenorphine. Differential interaction with opiate receptor subtypes in VIVO. J. Pharmacol Exp. Ther 223, 157–162.

Schmidt D. E. and Buxbaum D. M. (1978) Effect of acute morphine administration on regional acetylcholine turnover in the rat Brain Res. 147, 194–200.

Schubert D. P., Wuster M., Stoiber R, and Herz A. (1981) A selective distribution of different opiate receptors in certain areas of rat brain as revealed by in vitro autoradiography. Neurosci. Lett 21, 119–124.

Simantov R., Childers S. R, and Snyder S. H. (1978) The opiate receptor interaction of [³H]-methionine enkephalin. An opioid peptide. Eur J. Pharmacol. 47, 319–331.

Simon E. J., Hiller J. M, and Edelman I. (1973) Stereospecific binding of the potent narcotic analgesic [³H]-etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. USA 70, 1947–1949.

Simon E J., Hiller J. M., Edelman I, Groth J., and Stahl K. D. (1975a) Opiate receptors and their interactions with agonists and antagonists. Life Sci. 16, 1795–1800.

Simon E. J., Hiller J M, Groth J,and Edelman I (1975b) Further properties of stereospecific opiate binding sites in rat brain On the nature of the sodium effect J. Pharmacol Exp Ther. 192, 531–537.

Slater P. and Blundell C. (1979) Effects of morphine on amphetamine-induced circling and striatal cyclic AMP in rats and mice Neuropharmacology 18, 705–708.

Smith J. R. and Simon E. J. (1980) Selective protection of sterospecific enkephalin and opiate binding against inactivation by N-Ethylmaleimidine. Evidence for two classes of opiate receptors. Proc Natl. Acad. Sci USA 77, 281–284.

Snyder S. H. and Goodman R. R. (1980) Multiple neurotransmitter receptors. J. Neurochem. 35, 5–15

Spiegel K., Kourides I. A., and Pasternak G. W. (1982) Different receptors mediate morphine-induced prolactin and growth hormone release. Life Sci 31, 2177–2180

Spiegel K. and Pasternak G. W. (1984) Meptazmol: A novel mu-1 selective opiodal analgesic. J Pharmacol. Exp. Ther. 228, 414–419.

Sugrue M. F. (1974) The effects of acutely administered analgesics on the turnover of noradrenaline and dopamine in various regions of the rat brain Brit. J Pharmacol. 52, 159–165

Tepper P. and Woods J. H. (1978) Changes in locomotor activity and naloxone-induced lumping in mice produced by WIN 35, 197–2 (ethylketazocme), and morphine Psychopharmacology 58, 125–129

Trabucchi M., Poll A, Tonon G. C, and Spano P F. (1978) Interaction Among Enkephalinergic and Dopammergic Systems in Stiatum and Limbic Forebrain, in Catecholamines: Basic and Clinical frontiers (Usdin E, Kopin I J., and Barchas J., eds) Pergamon Press, New York, pp. 1053–1055.

Watson S. J., Akil H., Richard C W., and Barchas J. D. (1978) Evidence for two separate opiate peptide neuronal systems and the coexistence of β-lipotropin, β-endorphin, and ACTH immuno-reactivities in the same hypothalamus neurons. Nature (Lond.) 275, 226–228